Fig. 1 · Structure
Documents & Downloads
Chenodeoxycholic acid-13C
Stable Isotope
Chenodeoxycholic acid-13C is the stable isotope version of Chenodeoxycholic Acid, a hydrophobic primary bile acid. This compound primarily activates the farnesoid X receptor (FXR), playing a crucial role in regulating cholesterol metabolism. Chenodeoxycholic acid-13C can be used in metabolic studies and tracer experiments, providing insights into bile acid physiology and its impacts on lipid homeostasis.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 52918-92-0 |
| Applications | Stable Isotope |
| Formula | C2313CH40O4 |
| Molecular Weight | 393.56 |
| Synonyms | CDCA-13C |
| SMILES | C[C@@]12[C@](CC[C@]2([H])[C@H](C)CC[13C](O)=O)([H])[C@@]3([H])[C@@](CC1)([H])[C@@]4([C@](C[C@@H](CC4)O)([H])C[C@H]3O)C |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.